---
title: "India's Orchid Pharma eyes worst day in 4 years on Q3 profit drop"
date: "2025-02-13 16:23:42"
summary: "** Orchid Pharma tumbles 15.6% to 1,041.1 rupees** Stock set for worst day since November 2020, with trading volumes 9x the 30-day avg** Co posts 29% Y/Y fall in Q3 consolidated profit; net sales fell ~2%** Sharp price correction in export markets offset volume growth, said analysts at Systematix Institutional..."
categories:
  - "Reuters"
lang:
  - "en"
translations:
  - "en"
tags:
  - "Reuters"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

\*\* Orchid Pharma tumbles 15.6% to 1,041.1 rupees

\*\* Stock set for worst day since November 2020, with trading volumes 9x the 30-day avg

\*\* Co posts 29% Y/Y fall in Q3 consolidated profit; net sales fell ~2%

\*\* Sharp price correction in export markets offset volume growth, said analysts at Systematix Institutional Equities

\*\* Adds cash burn in branded formulation business also hurt

\*\* Stock eyes fifth straight session of falls, and has shed 42% so far this year

[Reuters](https://www.tradingview.com/news/reuters.com,2025:newsml_L4N3P40PE:0-india-s-orchid-pharma-eyes-worst-day-in-4-years-on-q3-profit-drop/)
